1. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score. (1st February 2022) Authors: Doets, Alex Y.; Lingsma, Hester F.; Walgaard, Christa; Islam, Badrul; Papri, Nowshin; Davidson, Amy; Yamagishi, Yuko; Kusunoki, Susumu; Dimachkie, Mazen M.; Waheed, Waqar; Kolb, Noah; Islam, Zhahirul; Mohammad, Quazi Deen; Harbo, Thomas; Sindrup, Soren H.; Chavada, Govindsinh; Willison, Hugh J.; ... Journal: Neurology Issue: Volume 98:Number 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan. (18th December 2014) Authors: Takedani, H.; Shima, M.; Horikoshi, Y.; Koyama, T.; Fukutake, K.; Kuwahara, M.; Ishiguro, N. Journal: Haemophilia Issue: Volume 21:Number 3(2015:May) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TGFβ1 signaling protects chondrocytes against oxidative stress via FOXO1–autophagy axis. Issue 11 (November 2021) Authors: Kurakazu, I.; Akasaki, Y.; Tsushima, H.; Sueishi, T.; Toya, M.; Kuwahara, M.; Uchida, T.; Lotz, M.K.; Nakashima, Y. Journal: Osteoarthritis and cartilage Issue: Volume 29:Issue 11(2021) Page Start: 1600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10‐year Japanese postmarketing surveillance data. Issue 1 (25th July 2016) Authors: Amano, K.; Seita, I.; Higasa, S.; Sawada, A.; Kuwahara, M.; Shima, M. Journal: Haemophilia Issue: Volume 23:Issue 1(2017) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗